Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

NA-Semax Amidate peptide icon, one bubble per amino acidNA-Semax Amidate7 residuesMEHFPGPEach bubble = one amino acid. Size = residue mass. Color = chemical class.

NA-Semax Amidate

Beginner tier: 100 mcg, daily · 2w on / 2w off · community consensus

CognitiveResearch
~5-10 min half-life·Nasal

Also known as: NA-Semax, N-Acetyl Semax Amidate, NASA (informal community abbreviation)

A single intranasal spray triggers a 3-fold increase in BDNF mRNA in the hippocampus, based on rodent data from the parent compound Semax [1]. NA-Semax Amidate (N-Acetyl Semax Amidate) is the stabilized, higher-potency version of Russia's approved nootropic peptide. No human clinical trials exist for this specific modification. The cognitive benefits persist 1 to 3 weeks after you stop dosing, which is why cycles run just 10 to 20 days. Nootropic users who want sharper focus, better verbal fluency, and sustained BDNF elevation without daily long-term dosing tend to reach for this one.

What Is NA-Semax Amidate?

NA-Semax Amidate (N-Acetyl Semax Amidate, CAS pending) is a stabilized derivative of Semax with an estimated 3 to 5 times greater potency per microgram. Dolotov and colleagues showed the parent compound Semax produced a three-fold BDNF mRNA increase from a single dose in rat hippocampus [1], and NA-Semax Amidate pushes the pharmacokinetics further.

The modification is straightforward. An N-terminal acetyl group blocks aminopeptidase degradation. A C-terminal amide cap blocks carboxypeptidase attack. The core sequence, ACTH(4-10) extended with Pro-Gly-Pro, stays identical to the parent compound approved in Russia for cognitive and neuroprotective indications. The result is a peptide that resists enzymatic breakdown in neural tissue longer than standard Semax, translating to an estimated 3 to 5 times greater potency per microgram.

In practice, experienced nootropic users dose 100 to 300 mcg intranasally each morning for 10 to 20 day cycles. The peptide activates melanocortin receptors (MC3R, MC4R) and upregulates both BDNF and NGF in the basal forebrain. It also modulates serotonergic, dopaminergic, and enkephalin signaling pathways. Community reports across roughly 50 to 100 Reddit threads describe improved verbal fluency, working memory, and stress resilience within the first few days, with peak cognitive effects by days 7 to 10.

The honest picture: zero human clinical trials exist for NA-Semax Amidate specifically. Every mechanistic citation traces back to the parent compound. PubMed returns about 12 results for "N-acetyl Semax" compared to roughly 150 for standard Semax. The potency multiplier is a pharmacokinetic inference, not a validated human comparison. Community experience across users who dose correctly has been consistently positive, but this is a preclinical compound with community-derived dosing.

How NA-Semax Amidate Works

NA-Semax Amidate is a synthetic analog of ACTH(4-10) extended with a Pro-Gly-Pro tripeptide tail. It activates melanocortin receptors MC3R and MC4R in the brain without triggering adrenal cortisol release, which separates it from full-length ACTH.

The primary neurotrophic action comes through BDNF upregulation. Dolotov and colleagues showed that a single application of Semax at 50 mcg/kg produced a 1.4-fold increase in BDNF protein and a 3-fold increase in exon III BDNF mRNA in the hippocampus [1]. TrkB receptor phosphorylation increased 1.6-fold in the same study. A separate group confirmed that Semax raises NGF levels in the basal forebrain [2].

Beyond neurotrophins, the peptide modulates serotonergic, dopaminergic, and enkephalin (opioid) signaling systems. This multi-pathway engagement likely explains the combined cognitive and mood effects that community users consistently describe.

The N-acetyl and amide modifications don't change receptor binding. They increase resistance to aminopeptidase and carboxypeptidase degradation. Magrì and colleagues studied N-terminal acetylation of Semax directly [3]; it is one of the few peer-reviewed studies of the modification. The practical effect is extended duration of activity in neural tissue compared to the parent compound.

NA-Semax Amidate Benefits

  • NA-Semax Amidate benefits center on neurotrophic upregulation and cognitive performance during short intranasal cycles.
  • Estimated 3 to 5 times more potent than standard Semax per microgram, meaning lower doses and shorter cycles can achieve equivalent or greater neurotrophic stimulation.
  • BDNF and NGF upregulation supports learning, memory consolidation, and neuroplasticity. Parent compound data shows 1.4-fold BDNF protein increase and 3-fold BDNF mRNA increase in rat hippocampus at 50 mcg/kg [1].
  • Neuroprotective effects confirmed in cerebral ischemia-reperfusion models. Genome-wide transcriptional analysis of Semax in focal ischemia identified changes in immune and vascular gene expression [4].
  • Mood stabilization and stress resilience through serotonin and dopamine pathway modulation. Community users report reduced anxiety at appropriate doses, improved motivation, and emotional steadiness during the cycle window.
  • Cognitive benefits persist 1 to 3 weeks after the cycle ends. BDNF and NGF protein levels remain raised post-cessation in rodent Semax models, making the off-period a productive continuation rather than a gap.
  • Users report 6 to 12 hours of cognitive effect per dose, compared to 2 to 4 hours with standard Semax. Onset is rapid at 5 to 15 minutes intranasal.

NA-Semax Amidate: Science vs Community Consensus

Partially Aligned
Scientific Evidence
Weak
Based on 5 key studies·Research only

No human clinical trials exist for NA-Semax Amidate specifically.

Dosing studied: Not established in humans. Rodent Semax precedent: 50 mcg/kg intranasal. No validated human equivalent dose for the amidate form. All human dosing is community-derived extrapolation.
Read the evidence (key study, limitations)

All mechanistic evidence derives from the parent compound Semax: approved in Russia for cognitive/neuroprotective indications and studied in human ischemia settings. The N-acetyl + C-terminal amide modifications are pharmacokinetically rational (protease resistance, extended intraneural duration) but unstudied in humans as a distinct compound. The 3–5× potency multiplier quoted here is a pharmacokinetic inference, not a formally validated human potency comparison.

Key Study

Dolotov et al. 2006 (PMID 16996037): Semax produces 3-fold BDNF mRNA increase and 1.6-fold TrkB phosphorylation in rat hippocampus at 50 mcg/kg (parent compound, not NA-Semax Amidate). For the acetylation itself, Magrì et al. 2016 (PMID 27586814) found that N-terminal acetylation changes how Semax binds copper. In neuroblastoma cells, the acetylated form did not protect against copper toxicity. It is one of the few peer-reviewed studies of the modification.

Limitations

No human RCTs for NA-Semax Amidate. PubMed count ~12 for "N-acetyl Semax" vs ~150 for parent Semax: extreme evidence gap for the modified form. Four of its five references are for parent Semax; the fifth studies N-acetyl Semax, and none tests the amidate form. Potency multiplier (3–5×) is a community estimate from pharmacokinetic reasoning, not a controlled human comparison. Its research status is preclinical.

Community Experience
Moderate
4.0/5
Based on ~50–100 Reddit threads (r/Nootropics, r/Peptides)

Positive but niche.

Community dosing: 100–600 mcg/day intranasal; most users settle at 100–300 mcg. Few experienced users push to 600 mcg. Some sources note 900 mcg/day as an upper ceiling but this is rarely reported in practice.
Read the reports (what users report 5, common issues 4)

Experienced nootropic users consistently report clear cognitive enhancement and mood stabilization at appropriate doses. Community consensus: superior duration and smoother profile than standard Semax at corrected dose. The #1 failure mode is treating it as equivalent-dose to parent Semax due to the 3–5× potency difference.

What users report (5)
  • Longer duration of cognitive effect vs parent Semax (community reports 6–12h vs 2–4h)
  • Rapid onset 15–30 min intranasal; noticeable verbal fluency and working memory improvement
  • Mood stabilization and anxiety reduction at appropriate doses (paradoxically: high doses cause anxiety)
  • Cognitive benefits persist 1–3 weeks post-cycle due to sustained BDNF/NGF elevation
  • Smoother stimulation profile than standard Semax at equivalent starting doses
Common issues (4)
  • Potency mismatch vs standard Semax: #1 user error; treating it as equivalent dose causes overstimulation and anxiety
  • Sleep disruption with late-day dosing (afternoon or evening use)
  • Higher cost per mg vs parent Semax; limited availability compared to Semax
  • Hair thinning reported at high doses by some users: rare, reportedly reversible, no clinical documentation
Partially Aligned

Community dosing, cycling rationale (10–20 day cycles), and route preference (intranasal) align with the Russian Semax clinical protocol tradition. Reported mechanism (BDNF upregulation, cognitive enhancement, neuroprotection) matches the validated parent compound mechanism. Divergent on the potency multiplier: community consensus of 3–5× is pharmacokinetically reasonable but not formally validated in humans. Science has no direct human data for NA-Semax Amidate; all parent-compound endorsement is inferred across the modification.

NA-Semax Amidate Dosage Guide

CommunityCommunity dosing consensus from peptide research communities
LevelDose / InjectionFrequency
Beginner100 mcg
DailyTrack
Moderate300 mcg
DailyTrack
Aggressive600 mcg
DailyTrack
Note:

Start at 100 mcg intranasal, period. The potency mismatch with standard Semax is the number one user error. If you were running Semax at 300 mcg, your starting dose here is 100 mcg.

Reconstitution math for intranasal: 10 mg vial plus 10 mL bacteriostatic water gives you 1 mg/mL (1000 mcg/mL). A standard nasal atomizer delivers about 0.1 mL per actuation, so each spray is 100 mcg. Three sprays gets you 300 mcg. Split across nostrils, wait 5 minutes between sides.

For subcutaneous (less common): 10 mg vial plus 4 mL bacteriostatic water gives you 2.5 mg/mL. On a U-100 insulin syringe, 100 mcg is 4 IU, 300 mcg is 12 IU, 600 mcg is 24 IU.

Dose before 10 AM. Nothing after 1 PM. The dopaminergic tail will wreck your sleep if you dose late. Refrigerate the reconstituted spray at 2 to 8 degrees C and toss it after 30 days. Lyophilized vials survive shipping better than pre-mixed sprays.

Cycling Protocol

On Period
2 weeks
Off Period
2 weeks

Standard protocol is 10-20 days on, 10-20 days off. Cognitive benefits often persist during the off period due to sustained BDNF elevation. Some users run 30-day cycles with longer breaks.

Calculate your NA-Semax Amidate dose
Free dosage calculator with syringe visualization

Or use the universal Peptide Calculator for any peptide.

NA-Semax Amidate Protocols by Goal

beginnerCommunity10–14 days on, 10–20 days off
Tolerance assessment
Wk 3–5 days
100 mcg · Once daily · Intranasal
Maintenance
Wk 7–11 days
100–200 mcg · Once daily · Intranasal

Expected: Improved focus, verbal fluency, and working memory within days 1–3. Mood stabilization by end of week 1. Cognitive benefits typically persist 1–2 weeks post-cycle.

Monitor: Track anxiety and sleep quality daily. Reduce or skip dose if waking earlier than baseline or noticing irritability building over consecutive days.

How to Use NA-Semax Amidate

  1. 1
    Reconstitute the vial

    Add 10 mL of bacteriostatic water to a 10 mg NA-Semax Amidate vial. This gives you 1 mg/mL (1000 mcg/mL). Swirl gently, do not shake. Let the powder dissolve fully.

  2. 2
    Load the nasal spray device

    Transfer the reconstituted solution into a calibrated nasal atomizer (0.1 mL per actuation). Each spray delivers 100 mcg.

  3. 3
    Clear your nasal passages

    A gentle saline rinse before dosing reduces irritation and improves absorption.

  4. 4
    Administer the dose

    Tilt your head slightly forward. Insert the spray tip into one nostril while closing the other. Press once and inhale gently. If your target dose is 200 mcg or higher, wait 5 minutes, then spray the other nostril.

  5. 5
    Time it right

    Dose in the morning, ideally before 10 AM. Do not dose after 1 PM. The stimulatory effects last 6 to 12 hours.

  6. 6
    Store properly

    Refrigerate the reconstituted spray at 2 to 8 degrees C. Discard after 30 days. Keep lyophilized (unreconstituted) vials at room temperature for up to 30 days, refrigerated for up to 24 months.

For subcutaneous injection (alternative route): reconstitute 10 mg in 4 mL bacteriostatic water for 2.5 mg/mL. Use a 29 to 31 gauge insulin syringe. 100 mcg equals 4 IU on a U-100 syringe. Inject into abdominal subcutaneous fat, rotate sites. Expect onset in 30 to 45 minutes versus 5 to 15 minutes intranasal.

Alternative Routes

Intranasal spray (primary / preferred)

Reference standard for all community dosing. Estimated intranasal bioavailability to CNS: 30–50% (improved over standard Semax due to amide cap; some sources cite up to 60%). Onset 5–15 min.

Reconstitute 10 mg vial in 10 mL BAC water = 1 mg/mL. Standard nasal atomizer at ~0.1 mL/actuation = 100 mcg per spray. Store reconstituted spray refrigerated at 2–8°C; discard after 30 days.

Subcutaneous injection (alternative)

Same mcg dosing as intranasal (no established dose adjustment). Onset ~30–45 min vs 5–15 min intranasal. Lower estimated CNS bioavailability per dose but more precise volumetric administration.

Reconstitute 10 mg vial in 4 mL BAC water = 2.5 mg/mL (2500 mcg/mL). Inject into abdominal subcutaneous fat; rotate sites. U-100 insulin syringe units: 100 mcg = 4 IU, 300 mcg = 12 IU, 600 mcg = 24 IU.

Mixing your own vial? Use the NA-Semax Amidate reconstitution calculator for the exact BAC-water-to-mcg math on any vial size.

NA-Semax Amidate Stacking Protocols

Works With

Selank

Complementary mechanism: Selank is GABAergic and anxiolytic; counters the stimulatory/dopaminergic profile of NA-Semax Amidate. Community describes the combination as "cognitive clarity + calm." The most frequently cited NA-Semax Amidate stack. Both are intranasal, allowing co-administration.

NA-Semax Amidate 100–300 mcg intranasal AM + Selank 250–500 mcg intranasal AM or midday. Can co-administer or stagger by 30 min.

Bromantane

Dopaminergic baseline support: Bromantane raises dopamine synthesis via tyrosine hydroxylase upregulation. Community stacks for enhanced motivational drive alongside BDNF/cognitive effects of NA-Semax Amidate. Monitor for additive stimulation.

NA-Semax Amidate 100–300 mcg intranasal AM + Bromantane 50–100 mg oral AM. Avoid if prone to anxiety.

Dihexa

Complementary neurotrophic axes: Dihexa targets HGF/c-Met pathway for synaptogenesis; NA-Semax Amidate targets BDNF/ACTH pathway. Community stacks for broader neurotrophic coverage. Both are research-only with no human safety data for the combination.

Dihexa 5–10 mg/day oral + NA-Semax Amidate 100–300 mcg intranasal AM. Run concurrent cycles (14–20 days on, 14–20 days off).

Alpha-GPC (300 mg)

Cholinergic support: community adds Alpha-GPC to support acetylcholine availability when BDNF-driven synaptic demand increases and to prevent headache patterns sometimes associated with increased synaptic activity. No pharmacological conflict with NA-Semax Amidate.

Alpha-GPC 300 mg oral AM, taken 30 min before intranasal NA-Semax Amidate.

Avoid

MAO inhibitors (phenelzine, tranylcypromine, selegiline)

NA-Semax Amidate upregulates serotonergic and dopaminergic signaling. Combining with MAOIs risks excessive monoamine accumulation and potential serotonin syndrome. Also listed under its drug interactions.

Do not combine
Amphetamines and CNS stimulants (methylphenidate, high-dose modafinil)

Additive CNS stimulation from overlapping dopaminergic upregulation. Substantially increases risk of anxiety, agitation, cardiovascular stress, and insomnia. Also listed under its drug interactions.

Anticoagulants (warfarin, heparin)

Parent compound Semax influences vascular gene expression (PMID 24661604). Precautionary: no direct interaction data for NA-Semax Amidate specifically.

Estimated Cost

Generic / Research
Research-grade: ~$35–65 per 10 mg lyophilized vial in the US as of Apr 2026. Common formulations: 10 mg powder vials (~$35–55), 10 mg/10 mL nasal spray (~$45–70), 20–30 mg vials. Significantly more expensive per mg than parent Semax. Research-grade products come as 10 mg, 20 mg, and 30 mg powders plus spray formats, some with ≥98.5% HPLC purity listed. Marketplace listings also exist (20 mg/10 mL, 240 mcg/spray). Verification JSON estimate was $30–60/10 mg; an Apr 2026 price check confirms the range.

Pricing updated 2026-04-09

NA-Semax Amidate Side Effects

Overstimulation is the most reported problem with NA-Semax Amidate, and it is almost always self-inflicted. The compound is 3 to 5 times more potent per microgram than standard Semax. Users who transfer their parent compound dose directly (e.g. 300 mcg Semax mapped straight to 300 mcg NA-Semax Amidate) experience anxiety, agitation, and irritability. This is the number one failure mode cited across community reports.

The anxiety response deserves emphasis. NA-Semax Amidate upregulates dopaminergic and serotonergic signaling. At higher doses, that stimulation tips from productive focus into agitation. Users with a history of anxiety disorders face increased risk; this compound is listed as contraindicated for severe anxiety disorders for exactly this reason. If anxiety appears, drop to 100 mcg and dose before 10 AM. Resolution typically happens within 1 to 2 days at the reduced dose.

Sleep disruption ranks second among community complaints. The dopaminergic upregulation has a 6 to 12 hour activity tail. Dosing after 1 PM is the primary cause. Shifting the dose earlier in the morning typically resolves sleep disruption within 2 to 3 days.

Hair thinning has been reported at sustained doses above 300 mcg per day over 30 or more days. The speculated mechanism involves melanocortin receptor (MC4R) activity. No clinical documentation exists for this effect; community reports indicate it reverses after cessation. The reports are rare.

Nasal irritation can occur with intranasal use. Reconstituting above 2.5 mg/mL concentration increases irritation risk. Using a saline rinse before dosing helps. If irritation persists, subcutaneous injection is an alternative route.

The human safety dataset is extremely limited. All published data comes from the parent compound Semax, not the amidate modification. PubMed returns about 12 results for the modified form. The researchStatus is correctly tagged as preclinical. No formal adverse event reporting exists.

Contraindications include pregnancy, breastfeeding, known hypersensitivity to Semax or ACTH-derived peptides, active bleeding disorders, and history of severe anxiety disorders. If combining with MAO inhibitors, the risk of excessive monoamine accumulation and serotonin syndrome is real; that combination should be avoided. Stimulant medications (amphetamines, methylphenidate) carry additive CNS stimulation risk. Anticoagulant users should monitor closely given Semax's documented influence on vascular gene expression [4].

Stop use and consult a physician if new anxiety disorder symptoms appear, if insomnia persists despite timing adjustments, or if blood pressure exceeds 140/90 mmHg.

Common Issues & Solutions

Anxiety or overstimulation: Almost always a dose mismatch: this compound is 3–5× more potent than standard Semax. Users who transfer their Semax dose directly will overdose. Reduce to 100 mcg, dose before 10 AM, avoid all other stimulants. Resolution expected within 1–2 days at reduced dose.

Sleep disruption: Late dosing is the primary cause. The dopaminergic upregulation has a 6–12h activity tail. All doses must be taken before 1 PM. Shifting dose timing earlier typically resolves sleep disruption within 2–3 days.

No noticeable effect: Verify reconstitution: 10 mg vial in 10 mL BAC water = 1000 mcg/mL = 100 mcg per 0.10 mL actuation. Confirm the nasal spray device is delivering the correct volume. If using SubQ, consider switching to intranasal for superior direct CNS access. Allow 5–7 full days before evaluating efficacy.

Hair thinning (rare): Community-reported at sustained high doses (>300 mcg/day over 30+ days). Speculated mechanism: melanocortin receptor (MC4R) activity. No clinical documentation; appears reversible after cessation. Reduce dose or discontinue if observed.

Nasal irritation: Dilute the spray solution: standard is 1 mg/mL (10 mg in 10 mL); going above 2.5 mg/mL increases irritation risk. Saline rinse before dosing helps. If persistent, switch to SubQ route.

Ask AI about this page

Ask AI for a second opinion on NA-Semax Amidate dosing and side effects

Contraindications

  • Pregnancy or planning to become pregnant
  • Breastfeeding
  • Known hypersensitivity to Semax or ACTH-derived peptides
  • Active bleeding disorders (peptide may influence immune/vascular gene expression)
  • History of severe anxiety disorders (may worsen at higher doses)

Drug Interactions

  • MAO inhibitors: potential for excessive serotonergic/dopaminergic stimulation
  • Stimulant medications (amphetamines, methylphenidate): additive CNS stimulation, use caution
  • Anticoagulants: Semax influences vascular gene expression; monitor if combining
  • Thyroid hormones: melanocortin pathway interactions; monitor thyroid function
  • Anticoagulants (warfarin, heparin)

Product Quality

Recommended Monitoring

TestWhenTarget
Blood pressureBaseline before first dose; mid-cycle (day 7); any time symptoms arise<130/80 mmHg at rest; hold dose and evaluate if >140/90 mmHg
Anxiety and mood self-assessmentDaily during cycleAny new or worsening anxiety disorder symptoms, persistent irritability, or insomnia → reduce dose or discontinue
Sleep quality logNightly throughout cycleSleep onset within 30 min of personal baseline; no significant early waking
Blood pressure

Melanocortin receptor (MC3R/MC4R) activation may influence vascular tone. Uncontrolled hypertension is a gap in peptides.ts contraindications: flagged in verification JSON; it is listed as a contraindication for parent Semax.

Anxiety and mood self-assessment

Overstimulation is the primary dose-limiting side effect. Daily tracking prevents normalization of gradually escalating anxiety over multiple dosing days.

Sleep quality log

Sleep disruption from late dosing is the second most common community complaint. Early detection allows timing adjustment before cumulative sleep debt develops.

NA-Semax Amidate Before and After

Days 1-3

Initial effects noticeable within hours of first dose: improved mental clarity, focus, and verbal fluency. Some users report mild stimulation or slight headache as the body adjusts.

Days 4-10

Cognitive effects become more consistent. Improved working memory, sustained attention, and motivation. Mood stabilization and reduced anxiety are commonly reported.

Days 11-14

Peak benefits during the latter half of the cycle. BDNF elevation reaches steady state. Enhanced learning capacity and stress resilience. End of standard 2-week cycle.

Post-cycle

Cognitive benefits often persist for 1-3 weeks after stopping, likely due to sustained BDNF and NGF levels. Effects gradually return to baseline.

What to Expect

Days 1 to 3, acute onset. Most users notice improved mental clarity and verbal fluency within hours of the first intranasal spray. Parent compound data from Dolotov [1] shows BDNF mRNA triples in the rat hippocampus within hours of application. Some mild stimulation is normal. Occasional slight headaches during the first day or two resolve as the body adjusts. Nasal irritation can occur if the solution concentration is too high.

Days 4 to 10, accumulating neurotrophic effects. This is where the cognitive response becomes steady and consistent. Working memory improves, sustained attention sharpens, and motivation picks up. Mood stabilization and stress resilience are commonly described during this window. BDNF protein elevation is sustained and building, based on Semax rodent kinetics. Anxiety or irritability during this phase almost always means the dose was escalated too quickly or timing shifted too late in the day.

Days 11 to 20, peak cycle and decision point. BDNF reaches steady-state based on Russian Semax clinical protocol precedent. Subjective benefits are at their highest. Improved learning capacity and stress resilience are typical. The standard 14-day cycle ends here; some users extend to 20 days. Diminishing marginal improvement can appear, with some users noticing habituation to the focus response past day 14.

Post-cycle, 1 to 3 weeks off. The off-period is productive, not empty. BDNF and NGF protein levels remain raised 1 to 2 weeks post-cessation in rodent models. Community users consistently report that cognitive benefits persist for 1 to 3 weeks after the last dose. The return to baseline is gradual rather than sudden. This persistent post-cycle benefit is the primary community rationale for cycling rather than continuous dosing.

Detailed Timeline: Science vs Community

Days 1–3
Science

Intranasal absorption via olfactory neuroepithelium within minutes. Parent Semax shows 3-fold BDNF mRNA increase within hours of application and TrkB phosphorylation by day 1 in rodent hippocampus (PMID 16996037). Acute melanocortin receptor binding expected from first dose.

Community

Most users notice mental clarity, verbal fluency, and improved focus within hours of first dose. Some mild stimulation. Occasional slight headache during first 1–2 days as body adjusts.

Days 4–10
Science

BDNF protein elevation sustained and accumulating based on Semax rodent data. TrkB phosphorylation and NGF upregulation in basal forebrain build through this window. Serotonergic and dopaminergic pathway modulation stabilizes.

Community

Cognitive effects become consistent and stable. Improved working memory, sustained attention, motivation, and mood. Stress resilience commonly described. Most users identify this as the most productive phase.

Days 11–20
Science

BDNF steady-state based on Russian Semax clinical protocol precedent. 10–20 day cycle length follows original Russian Semax clinical protocol; no direct human data defines the optimal cycle length for NA-Semax Amidate specifically.

Community

Peak subjective benefits. Enhanced learning capacity and stress resilience. Standard 14-day cycle ends here; some users extend to 20–30 days without reported tolerance build.

Post-cycle (1–3 weeks off)
Science

BDNF and NGF protein levels remain elevated 1–2 weeks post-cessation in rodent Semax models. Structural plasticity changes, if any, may persist beyond drug clearance. N-acetyl/amide modifications extend intraneural residence time vs parent: off-period benefits may exceed those seen with standard Semax.

Community

Cognitive benefits persist for 1–3 weeks post-cycle. Gradual return to baseline rather than a sharp drop-off. The persistent benefit post-cycle is the primary community rationale for the cycling protocol.

Pharmacokinetics

Half-Life
8min
Bioavailability
Intranasal: estimated 30-50% (improved over standard Semax due to amide cap)
Tmax
~5-10 minutes (intranasal)
Data Confidence
low

Source: Estimated from Semax PK data; acetylation/amidation extend half-life vs parent compound (~2-3 min IV)

Pharmacokinetics: Active Dose Over Time

t½ = ~5-10 min (intranasal)

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.

Molecular Profile

Amino Acids
7
Sequence
MEHFPGP
HydrophobicPolarPositiveNegativeSpecialHow we generate these icons
Identifiers
CAS: Not available (no CAS registry entry found for the modified form)

Who Should Consider NA-Semax Amidate

  • Individuals seeking cognitive enhancement and improved focus
  • Those wanting a more potent and stable alternative to standard Semax
  • People interested in neuroprotection and BDNF upregulation
  • Users with stress-related cognitive decline or brain fog

Related Peptides

What Changed for NA-Semax Amidate

No material change since Oct 5, 2026. Checked against Federal Register, openFDA Drugs@FDA, openFDA drug labels, openFDA enforcement reports and PubMed retraction links on Oct 14, 2026. How the change record works

Peptide Schedule Research TeamReviewed Apr 7, 20265 Citations

References

  1. [1]Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus (opens in a new tab)PubMed (opens in a new tab)PubMed
  2. [2]Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain (opens in a new tab)PubMed (opens in a new tab)PubMed
  3. [3]Influence of the N-terminus acetylation of Semax on copper(II) and zinc(II) coordination and biological properties (Magri et al., J Inorg Biochem 2016) (opens in a new tab)PubMed (opens in a new tab)PubMed
  4. [4]The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis (opens in a new tab)PubMed (opens in a new tab)PubMed

Related Tools

Storage & Stability

Before Reconstitution
Room temperature up to 30 days, refrigerated up to 24 months, -20°C for long-term
After Reconstitution
Refrigerate at 2-8°C, use within 14 days. Nasal spray solutions stable up to 30 days refrigerated.
Temperature
2-8°C (36-46°F) after reconstitution

Frequently Asked Questions

Yes, roughly 3-5x more potent per microgram. The N-acetyl blocks aminopeptidase degradation and the C-terminal amide blocks carboxypeptidase. If you're used to 300 mcg of regular Semax, start NA-Semax Amidate at 100 mcg and work up slowly.

Almost always a dosing issue. The dopaminergic and serotonergic upregulation at higher doses tips into agitation. Start at 100 mcg, dose before noon, and don't combine it with other stimulants. That fixes it for most people.

Some users on forums report it at higher doses over longer cycles, possibly related to melanocortin receptor (MC4R) activity. There's no clinical documentation and it appears rare. Reports suggest it reverses after stopping.

That follows the original Russian Semax clinical protocols. The cognitive benefits from BDNF and NGF upregulation persist 1-3 weeks after you stop, so longer continuous use gives diminishing returns. The off-period also prevents receptor desensitization.

You can, but intranasal is preferred because the olfactory pathway gives direct CNS access. SubQ means the peptide has to cross the blood-brain barrier from systemic circulation, which likely reduces how much actually reaches the brain. Same mcg dosing applies for SubQ, but expect slower onset: about 30-45 minutes vs 5-15 minutes intranasal.